Fig. 4

Prognostic efficacy verification of CuAS. A Expression patterns of 11 prognostic marker genes in TCGA samples. B Differences in overall survival among CuAS score groups in TCGA samples. C Significant differences in overall survival among CuAS score groups in validation set CGGA1. D Significant differences in overall survival among CuAS score groups in validation set CGGA2. E The predictive efficacy of CuAS scores in TCGA samples for patient survival. Univariate Cox regression was used to evaluate the prognostic efficacy of CuAS scores and clinical features in (F) TCGA samples and (G) validation set CGGA2. Multivariate Cox regression was used to evaluate the independence of prognostic efficacy of CuAS scores and clinical features in (H) TCGA samples and (I) validation set CGGA2